Barbara Gayle Duncan's Net Worth
Barbara Gayle Duncan's net worth is estimated to be at least $5,606,209.37 as of 12/23/2024. CoreStreet's estimation of Barbara Gayle Duncan's net worth is based on their sale of stock and current holding of stock.
Barbara Gayle Duncan is Director at Jounce Therapeutics Inc. They have executed at least 17 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of JNCE stock on 09/15/2020. Their biggest sale was on 06/19/2013 when they sold 50,575 units of Intercept Pharmaceuticals Inc stock for $1,744,837.50. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $5,606,209.37
Most recent insider trade:
- Sept. 15, 2020
Barbara Gayle Duncan's Insider Trading History
| Jounce Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 15, 2020 | Director | 10,000 | $10.00 | Sell | $100,000.00 |
March 15, 2018 | Director | 2,000 | $28.11 | Sell | $56,220.00 |
Jan. 26, 2018 | Director | 4,000 | $25.00 | Sell | $100,000.00 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 3, 2016 | CAO | 147 | $163.20 | Sell | $23,990.40 |
July 5, 2016 | CAO | 146 | $145.11 | Sell | $21,186.06 |
April 4, 2016 | CFO | 144 | $130.76 | Sell | $18,829.44 |
Jan. 4, 2016 | CFO | 468 | $145.90 | Sell | $68,281.20 |
Oct. 2, 2015 | CFO | 1,054 | $163.17 | Sell | $171,981.18 |
July 1, 2015 | CFO | 1,000 | $242.10 | Sell | $242,100.00 |
Jan. 5, 2015 | CFO | 141 | $176.49 | Sell | $24,885.09 |
Jan. 2, 2015 | CFO | 1,000 | $156.40 | Sell | $156,400.00 |
Oct. 1, 2014 | CFO | 1,000 | $233.12 | Sell | $233,120.00 |
April 14, 2014 | CFO | 1,154 | $279.00 | Sell | $321,966.00 |
July 8, 2013 | CFO | 25,000 | $45.39 | Sell | $1,134,750.00 |
June 19, 2013 | CFO | 50,575 | $34.50 | Sell | $1,744,837.50 |
May 28, 2013 | CFO | 6,225 | $34.50 | Sell | $214,762.50 |
May 20, 2013 | CFO | 28,200 | $34.50 | Sell | $972,900.00 |